Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,452 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,452 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,452 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,452 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,452 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,452 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,452 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
ROTE WILLIAM E. Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
BENDHEIM JACK President and CEO · indirect
Sold on a plan 2×
$400.61K 9,660 at 41.47
30.2%
Planned (10b5-1)
3 Feb 2026
Williams Michael S Chief Executive Officer
Sold on a plan
$399.93K 19,017 at 21.03
2.7%
Planned (10b5-1)
3 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Fauber Robert President and CEO
Sold on a plan
$286.87K 575 at 498.90
0.9%
Planned (10b5-1)
3 Feb 2026
FOLGER ANTHONY Chief Financial Officer
Sold on a plan 2×
$240.01K 6,000 at 40.00
10.9%
Planned (10b5-1)
3 Feb 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan 2×
$178.87K 16,403 at 10.90
0.6%
Planned (10b5-1)
3 Feb 2026
Singh Ritadhwaja Jebens EVP & CHIEF DIGITAL OFFICER
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
Claussen James J Executive Vice President & CFO
Sold on a plan
$149.16K 4,972 at 30.00
6.3%
Planned (10b5-1)
3 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
INGLIS ANDREW G Chairman and CEO
Sold on a plan
$141.87K 103,554 at 1.37
2.4%
Planned (10b5-1)
3 Feb 2026
Okupe Oluyemi Chief Financial Officer
Sold on a plan
$139.11K 5,262 at 26.44
5.4%
Planned (10b5-1)
3 Feb 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan
$127.72K 3,200 at 39.91
3.6%
Planned (10b5-1)
3 Feb 2026
Indelicarto Thomas C EVP, Gen Counsel & Secretary
Sold on a plan 2×
$124.04K 498 at 249.08
1.6%
Planned (10b5-1)
3 Feb 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan
$123.84K 795 at 155.77
0.9%
Planned (10b5-1)
3 Feb 2026
Foehr David Senior VP, Finance and PAO
Sold on a plan 2×
$111.12K 5,556 at 20.00
22.7%
Planned (10b5-1)
3 Feb 2026
Sold on a plan 2×
$109.90K 10,000 at 10.99
0.5%
Planned (10b5-1)
3 Feb 2026
Sheena Jonathan Director
Sold on a plan
$100.38K 435 at 230.77
0.2%
Planned (10b5-1)
3 Feb 2026
Sold on a plan
$96.50K 10,500 at 9.19
14.4%
Planned (10b5-1)
3 Feb 2026
Schulz Tamara L Chief Accounting Officer
Sold on a plan
$91.31K 1,527 at 59.80
1.5%
Planned (10b5-1)
3 Feb 2026
Smith Chad M. Pres & COO, Better Mortgage · indirect
Sold on a plan
$83.80K 3,097 at 27.06
14.3%
Planned (10b5-1)
3 Feb 2026
Yi Steven See Remarks
Sold on a plan
$80.33K 8,000 at 10.04
0.3%
Planned (10b5-1)
3 Feb 2026
Shah Nealesh D. SVP and CFO
Sold on a plan
$74.57K 54,434 at 1.37
3.1%
Planned (10b5-1)
3 Feb 2026
Nonko Eugene Director · indirect
Sold on a plan
$67.42K 6,700 at 10.06
0.5%
Planned (10b5-1)
3 Feb 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$62.31K 4,170 at 14.94
2.6%
Planned (10b5-1)
3 Feb 2026
WESTBROOKS KRISTOPHER R President & COO
Sold on a plan
$62.06K 2,951 at 21.03
1.5%
Planned (10b5-1)
3 Feb 2026
SCHRAMM LYRA AMBER Chief People Officer
Sold on a plan
$55.99K 199 at 281.37
52.9%
Sold half or more
3 Feb 2026
Nonko Eugene Director
Sold on a plan
$54.33K 5,400 at 10.06
0.6%
Planned (10b5-1)
3 Feb 2026
Charlton Rebecca L SVP, Controller & CAO
Sold on a plan
$47.49K 843 at 56.34
5.7%
Planned (10b5-1)
3 Feb 2026
Weaver Erik EVP & Chief Financial Officer
Sold on a plan
$44.65K 1,493 at 29.90
1.9%
Planned (10b5-1)
3 Feb 2026
Jedrzejek David SVP and General Counsel
Sold on a plan
$44.06K 2,248 at 19.60
2.1%
Planned (10b5-1)
3 Feb 2026
Ohlgart Christiane Chief Financial Officer
Sold on a plan
$40.93K 507 at 80.73
5.8%
Planned (10b5-1)
3 Feb 2026
Sangiovanni Timothy J. SVP, Finance & Corp Controller
Sold on a plan
$27.55K 3,000 at 9.18
9.2%
Planned (10b5-1)
3 Feb 2026
Marion Josh R. SVP and General Counsel
Sold on a plan
$26.93K 19,656 at 1.37
9.1%
Planned (10b5-1)
3 Feb 2026
Glass Ronald W. VP & Chief Accounting Officer
Sold on a plan
$26.42K 19,285 at 1.37
5.3%
Planned (10b5-1)
3 Feb 2026
Sellers Jeanette SVP of Accounting
Sold on a plan
$24.85K 1,330 at 18.68
2.8%
Planned (10b5-1)
3 Feb 2026
Sharma Manish Chief Strategy & Services Ofcr
Sold on a plan
$24.54K 98 at 250.36
1.9%
Planned (10b5-1)
3 Feb 2026
MALCOLM JAN Director
Sold on a plan
$23.71K 50 at 474.23
15.6%
Planned (10b5-1)
3 Feb 2026
SIEGEL IAN H. CHIEF EXECUTIVE OFFICER · indirect
Sold on a plan
$21.83K 9,722 at 2.25
15.5%
Planned (10b5-1)
3 Feb 2026
Sold on a plan
$15.25K 25,000 at 0.61
25.0%
Planned (10b5-1)
3 Feb 2026
Still Ashley Director
Sold on a plan
$13.07K 63 at 207.42
2.7%
Planned (10b5-1)
3 Feb 2026
Burgum Melissa A Chief Accounting Officer
Sold on a plan
$3.76K 15 at 250.43
0.2%
Planned (10b5-1)
3 Feb 2026
Vultaggio Vincent PAO and PFO
Sold on a plan
$1.40K 556 at 2.52
0.3%
Planned (10b5-1)
2 Feb 2026
Stein Kevin M Director · indirect
Sold on a plan 32×
$68.53M 48,000 at 1,427.79
85.5%
Sold half or more
2 Feb 2026
HASTINGS REED Director
Sold on a plan 3×
$32.70M 390,970 at 83.63
99.0%
Sold half or more
2 Feb 2026
FRIEDMAN ADENA T Chair and CEO
Sold on a plan
$29.07M 300,000 at 96.91
13.5%
Planned (10b5-1)
2 Feb 2026
Swift Christopher Chairman and CEO
Sold on a plan 6×
$27.55M 201,938 at 136.41
50.9%
Sold half or more
2 Feb 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 6×
$19.68M 85,299 at 230.72
40.0%
Planned (10b5-1)
Showing 17,651–17,700 of 23,452. ← Newer Page 354 of 470 Older →